
Waters (WAT) Stock Forecast & Price Target
Waters (WAT) Analyst Ratings
Bulls say
Waters is a leader in analytical instruments, with a focus on liquid chromatography, mass spectrometry, and thermal analysis tools. The recent merger with Becton Dickinson's life science and diagnostics business has increased its concentration in diagnostics and discovery-related life science tools, making them a prominent player in these growing markets. The company has a strong track record of successful acquisitions and turnaround efforts, and with a significant exposure to drug manufacturing and favorable industry consolidation trends, there is potential for continued growth and a positive outlook for Waters's stock.
Bears say
Waters is facing significant challenges, such as integrating the recent acquisition of Becton Dickinson's life science and diagnostics business while also facing industry headwinds and potential dilution of organic sales growth. Additionally, its balance sheet is constrained by high levels of debt, limiting its potential for strategic or tactical moves in the near term. The company's sustainability issues, including environmental concerns and human capital management, may impact its long-term performance and reputation.
This aggregate rating is based on analysts' research of Waters and is not a guaranteed prediction by Public.com or investment advice.
Waters (WAT) Analyst Forecast & Price Prediction
Start investing in Waters (WAT)
Order type
Buy in
Order amount
Est. shares
0 shares